-
1.发明公开HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION 有权杂环醚和硫醚类化合物适用于控制化学突触传递
公开(公告)号：EP1047690A1
公开(公告)日：2000-11-02
申请号：EP98964167.5
申请日：1998-12-18
Applicant: Abbott Laboratories
Inventor： HOLLADAY, Mark, W. , ABREO, Melwyn, A. , GUNN, David, E. , LIN, Nan-Horng , GARVEY, David, S. , RYTHER, Keith , LEBOLD, Suzanne, A. , ELLIOTT, Richard, L. , HE, Yun , WASIAK, James, T. , BAI, Hao , DART, Michael, J. , EHRLICH, Paul, P. , LI, Yihong , KINCAID, John, F. , SCHKERYANTZ, Jeffrey, M. , LYNCH, John, K.
IPC: C07D401/12 , C07D403/12 , C07D417/12 , C07D487/04 , C07D455/02 , A61K31/44 , A61K31/40 , A61K31/425 , A61K31/50 , A61K31/505 , A61K31/47
CPC classification number: C07D401/12 , C07D403/12 , C07D417/12 , C07D455/02 , C07D487/04
Abstract: Novel compounds having formulas (I), (II) or (III) or pharmaceutically-acceptable salts or prodrugs thereof, which are useful for controlling synaptic transmission; to therapeutically-effective pharmaceutical compositions of these compounds; and to the use of said compositions to controlling synaptic transmission in human or veterinary patients.
-
2.发明授权HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION 有权杂环醚和硫醚类化合物适用于控制化学突触传递
公开(公告)号：EP1047690B1
公开(公告)日：2004-03-24
申请号：EP98964167.5
申请日：1998-12-18
Applicant: Abbott Laboratories
Inventor： HOLLADAY, Mark, W. , ABREO, Melwyn, A. , GUNN, David, E. , LIN, Nan-Horng , GARVEY, David, S. , RYTHER, Keith , LEBOLD, Suzanne, A. , ELLIOTT, Richard, L. , HE, Yun , WASIAK, James, T. , BAI, Hao , DART, Michael, J. , EHRLICH, Paul, P. , LI, Yihong , KINCAID, John, F. , SCHKERYANTZ, Jeffrey, M. , LYNCH, John, K.
IPC: C07D401/12 , C07D403/12 , C07D417/12 , C07D487/04 , C07D455/02 , A61K31/44 , A61K31/40 , A61K31/425 , A61K31/50 , A61K31/505 , A61K31/47
CPC classification number: C07D401/12 , C07D403/12 , C07D417/12 , C07D455/02 , C07D487/04
Abstract: Novel compounds having formulas (I), (II) or (III) or pharmaceutically-acceptable salts or prodrugs thereof, which are useful for controlling synaptic transmission; to therapeutically-effective pharmaceutical compositions of these compounds; and to the use of said compositions to controlling synaptic transmission in human or veterinary patients.
-
Search Results
2
records
(took 0.025 seconds)
